Antimicrobial Peptides and Proteins

Name: Antimicrobial Peptides and Proteins
Price: 311.95 AUD
Availability: OutOfStock
ISBN: 9780443345197

Rossen Donev (Head of Research, MicroPharm Limited, UK)

$311.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
23 January 2026

Biophysics; Biochemistry; Molecular biology

Series: Advances in Protein Chemistry and Structural Biology

Antimicrobial Peptides and Proteins

Series edited by: Rossen Donev (Head of Research MicroPharm Limited UK)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 229mm, Width: 152mm,
Weight: 450g
ISBN: 9780443345197
ISBN 10: 0443345198
Series: Advances in Protein Chemistry and Structural Biology
Pages: 462
Publication Date: 23 January 2026
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

1. Nature and mechanistic action of Antimicrobial Peptides Selvaraj Chandrabose Sr. 2. TBC Sibel Kalyoncu Uzunlar 3. Advances in elucidation molecular targets and mechanisms of action of AMPs: beyond membrane disruption Olga Shamova, Igor Eliseev and Dmitriy Orlov 4. Discovery, Design, and Applications of Antimicrobial Peptides Jiamiao Hu 5. TBC Vijay Kumar Prajapati 6. TBC Vijay Kumar Prajapati 7. Designing Potent Antimicrobial Peptides Against Acinetobacter baumannii: A Combined Approach Using Genetic Algorithms and Machine Learning Strategies George Priya Doss Priya Doss C 8. Protection of Diabetic Wound Patients from Invasive Bacterial Infections by Innate Antimicrobial Peptides George Priya Doss Priya Doss C 9. Bacteriophage Lysins as a potential therapeutic strategy for Methicillin Resistant Staphylococcus aureus infections Dileep Francis 10. Structural insights and therapeutic potential of host defence peptides in combatting antimicrobial resistance Octávio Luiz Franco Sr. 11. Antimicrobial protein as a cargo for antimicrobial nanomaterials to combat Gram-negative bacteria Karol Ciepluch 12. Unravelling the Role of Antimicrobial Proteins in Leptospirosis: A Comprehensive Transcriptomic Analysis Karthick Vasudevan, Prasanna Kumar Selvam, Nivedya Kottarath and Megha Hari 13. Deciphering Antimicrobial Peptide (AMP) Resistance Mechanisms in Enterococcus faecalis Through Integrated RNA-Seq and Hub Genes Identification Karthick Vasudevan, Deepika J, Aishwarya C Shetty and T DhanushKumar

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.